ReviewGenes2026
DNA Mixture Deconvolution: A Four-Strategy Framework from Physical Separation to Database Searching.
Review in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
DNA mixture interpretation remains one of the most technically demanding challenges in forensic genetics. While probabilistic genotyping (PG) systems have substantially advanced likelihood ratio (LR) evaluation, comparatively less attention has been devoted to the systematic reconstruction of contributor genotypes, particularly in no-suspect and database-search contexts. This review synthesizes recent developments in DNA mixture deconvolution through a four-strategy framework: (i) physical and biological separation, (ii) high-information genetic markers, (iii) continuous probabilistic algorithms, and (iv) integration with database searching infrastructures. Upstream approaches, including single-cell isolation and sequencing, reduce mixture complexity at the molecular level. Marker innovations such as microhaplotypes, MiniHaps and DIP-STRs increase per-locus information content and enhance resistance to degradation. Downstream probabilistic models-extended from STRs to SNPs and microhaplotypes-leverage quantitative signal data to infer contributor genotypes, with recent advances in Hamiltonian Monte Carlo, variational inference, and deep learning improving inferential stability and reconstruction accuracy. Importantly, genotype deconvolution and LR evaluation represent mathematically distinct objectives, requiring different validation metrics and potentially separate architectural optimization. The convergence of molecular innovation, algorithmic refinement, and LR-based database searching is progressively transforming mixture interpretation from a purely evidential assessment into an integrated investigative framework. Future progress will depend on standardized marker panels, deconvolution-specific performance metrics, and scalable LR-enabled database infrastructures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.